Operating Lease, Right-of-Use Asset of Lunai Bioworks Inc. from 02 Jul 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lunai Bioworks Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 02 Jul 2019 to 30 Jun 2025.
  • Lunai Bioworks Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $687,371, a 46% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Lunai Bioworks Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $687,371 -$582,262 -46% 30 Jun 2025 10-Q 14 Nov 2025 2026 Q1
Q1 2025 $992,357 -$393,262 -28% 31 Mar 2025 10-Q 15 May 2025 2025 Q3
Q4 2024 $1,180,799 +$368,108 +45% 31 Dec 2024 10-Q 19 Feb 2025 2025 Q2
Q3 2024 $1,150,474 +$286,876 +33% 30 Sep 2024 10-Q/A 19 Feb 2025 2025 Q1
Q2 2024 $1,269,633 +$355,648 +39% 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q1 2024 $1,385,619 +$421,750 +44% 31 Mar 2024 10-Q/A 19 Feb 2025 2024 Q3
Q4 2023 $812,691 -$200,565 -20% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 $863,598 -$198,552 -19% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 $913,985 -$243,101 -21% 30 Jun 2023 10-K/A 19 Feb 2025 2024 FY
Q1 2023 $963,869 -$264,021 -22% 31 Mar 2023 10-Q 12 May 2023 2023 Q3
Q4 2022 $1,013,256 -$284,708 -22% 31 Dec 2022 10-Q 09 Mar 2023 2023 Q2
Q3 2022 $1,062,150 -$305,171 -22% 30 Sep 2022 10-Q 07 Mar 2023 2023 Q1
Q2 2022 $1,157,086 -$278,892 -19% 30 Jun 2022 10-K 02 Oct 2023 2023 FY
Q1 2022 $1,227,890 -$276,061 -18% 31 Mar 2022 10-Q 13 May 2022 2022 Q3
Q4 2021 $1,297,964 -$273,284 -17% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q2
Q3 2021 $1,367,321 -$270,557 -17% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q1
Q2 2021 $1,435,978 -$267,881 -16% 30 Jun 2021 10-K 27 Feb 2023 2022 FY
Q1 2021 $1,503,951 -$265,258 -15% 31 Mar 2021 10-Q 17 May 2021 2021 Q3
Q4 2020 $1,571,248 -$262,685 -14% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q2
Q3 2020 $1,637,878 -$347,256 -17% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q1
Q2 2020 $1,703,859 -$257,685 -13% 30 Jun 2020 10-K 24 Sep 2021 2021 FY
Q1 2020 $1,769,209 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $1,833,933 31 Dec 2019 10-Q 10 Feb 2020 2020 Q2
Q3 2019 $1,985,134 30 Sep 2019 10-Q 13 Nov 2019 2020 Q1
Q2 2019 $1,961,544 02 Jul 2019 10-Q 11 May 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.